1. Home
  2. MSW vs CTXR Comparison

MSW vs CTXR Comparison

Compare MSW & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSW
  • CTXR
  • Stock Information
  • Founded
  • MSW 2012
  • CTXR 2007
  • Country
  • MSW Hong Kong
  • CTXR United States
  • Employees
  • MSW N/A
  • CTXR N/A
  • Industry
  • MSW
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • MSW
  • CTXR Health Care
  • Exchange
  • MSW NYSE
  • CTXR Nasdaq
  • Market Cap
  • MSW 78.0M
  • CTXR 84.9M
  • IPO Year
  • MSW 2024
  • CTXR N/A
  • Fundamental
  • Price
  • MSW $5.12
  • CTXR $2.65
  • Analyst Decision
  • MSW
  • CTXR Buy
  • Analyst Count
  • MSW 0
  • CTXR 2
  • Target Price
  • MSW N/A
  • CTXR $100.00
  • AVG Volume (30 Days)
  • MSW 151.7K
  • CTXR 561.0K
  • Earning Date
  • MSW 01-01-0001
  • CTXR 02-12-2025
  • Dividend Yield
  • MSW N/A
  • CTXR N/A
  • EPS Growth
  • MSW N/A
  • CTXR N/A
  • EPS
  • MSW 0.21
  • CTXR N/A
  • Revenue
  • MSW $27,572,692.00
  • CTXR N/A
  • Revenue This Year
  • MSW N/A
  • CTXR N/A
  • Revenue Next Year
  • MSW N/A
  • CTXR N/A
  • P/E Ratio
  • MSW $28.24
  • CTXR N/A
  • Revenue Growth
  • MSW 26.09
  • CTXR N/A
  • 52 Week Low
  • MSW $4.72
  • CTXR $2.44
  • 52 Week High
  • MSW $8.13
  • CTXR $26.75
  • Technical
  • Relative Strength Index (RSI)
  • MSW N/A
  • CTXR 30.59
  • Support Level
  • MSW N/A
  • CTXR $2.44
  • Resistance Level
  • MSW N/A
  • CTXR $2.85
  • Average True Range (ATR)
  • MSW 0.00
  • CTXR 0.34
  • MACD
  • MSW 0.00
  • CTXR 0.15
  • Stochastic Oscillator
  • MSW 0.00
  • CTXR 24.99

About MSW MING SHING GROUP HOLDINGS LIMITED

Ming Shing Group Holdings Ltd is a holding company, which is primarily operated through its indirectly wholly-owned Hong Kong Operating Subsidiaries, MS (HK) Engineering Limited and MS Engineering Co., Limited. It is engaged in wet trades works, such as plastering works, tile laying works, brick laying works, floor screeding works and marble works. the company is mainly engaged in private-sector projects in Hong Kong. Its private sector projects mainly involve private residential developments and commercial developments. The project owners of its private sector projects are generally property developers, and its customers are generally main contractors and wet trades work subcontractors engaged under such projects.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

Share on Social Networks: